{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:35:42Z","timestamp":1772786142478,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jpba.2020.113154","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T11:39:12Z","timestamp":1580989152000},"page":"113154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Tissue distribution of 35S-metabolically labeled neublastin (BG00010) in rats"],"prefix":"10.1016","volume":"184","author":[{"given":"Natalia","family":"Penner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shobha","family":"Purushothama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blake","family":"Pepinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2020.113154_bib0005","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0896-6273(00)80649-2","article-title":"Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex","volume":"21","author":"Baloh","year":"1998","journal-title":"Neuron."},{"key":"10.1016\/j.jpba.2020.113154_bib0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn812","article-title":"The GDNF family: signalling, biological functions and therapeutic value","volume":"3","author":"Airaksinen","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jpba.2020.113154_bib0015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2174\/1568026054367593","article-title":"New approaches for the treatment of pain: the GDNF family of neurotrophic growth factors","volume":"5","author":"Sah","year":"2005","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jpba.2020.113154_bib0020","doi-asserted-by":"crossref","first-page":"11585","DOI":"10.1073\/pnas.1003287107","article-title":"Topographically specific regeneration of sensory axons in the spinal cord","volume":"107","author":"Harvey","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.jpba.2020.113154_bib0025","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.pain.2013.11.007","article-title":"Artemin induced functional recovery and reinnervation after partial nerve injury","volume":"155","author":"Wang","year":"2014","journal-title":"Pain."},{"key":"10.1016\/j.jpba.2020.113154_bib0030","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1073\/pnas.1502057112","article-title":"Artemin promotes functional long-distance axonal regeneration to the brainstem after dorsal root crush","volume":"112","author":"Wong","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.jpba.2020.113154_bib0035","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1021\/bi049247p","article-title":"Glial cell line-derived neurotrophic factor (GDNF) receptor alpha-1 (GFR alpha1) is highly selective for GDNF versus artemin","volume":"44","author":"Carmillo","year":"2005","journal-title":"Biochemistry."},{"key":"10.1016\/j.jpba.2020.113154_bib0040","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1046\/j.0953-816x.2001.01596.x","article-title":"GFRalpha3 is expressed predominantly in nociceptive sensory neurons","volume":"13","author":"Orozco","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jpba.2020.113154_bib0045","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm944","article-title":"Multiple actions of systemic artemin in experimental neuropathy","volume":"9","author":"Gardell","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.jpba.2020.113154_bib0050","doi-asserted-by":"crossref","first-page":"10018","DOI":"10.1074\/jbc.M114.602268","article-title":"Quantitative analysis of receptor tyrosine kinase-effector coupling at functionally relevant stimulus levels","volume":"290","author":"Li","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpba.2020.113154_bib0055","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1529-8027.2006.00106.x","article-title":"Artemin has potent neurotrophic actions on injured C-fibres","volume":"11","author":"Bennett","year":"2006","journal-title":"J. Peripher. Nerv. Syst."},{"key":"10.1016\/j.jpba.2020.113154_bib0060","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s11095-016-1880-x","article-title":"Investigating the Role of Artemin Glycosylation","volume":"33","author":"Danwen","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2020.113154_bib0065","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/bcp.12941","article-title":"Pharmacokinetics and pharmacodynamics of multiple doses of BG00010, a neurotrophic factor with anti-hyperalgesic effects, in patients with sciatica","volume":"82","author":"Okkerse","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2020.113154_bib0070","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1097\/j.pain.0000000000000983","article-title":"Safety and efficacy of neublastin in painful lumbosacral radiculopathy: a randomized, double-blinded, placebo-controlled phase 2 trial using Bayesian adaptive design (the SPRINT trial)","volume":"158","author":"Backonja","year":"2017","journal-title":"Pain."},{"key":"10.1016\/j.jpba.2020.113154_bib0075","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1021\/bi060035x","article-title":"Artemin crystal structure reveals insights into heparan sulfate binding","volume":"45","author":"Silvian","year":"2006","journal-title":"Biochemistry."},{"key":"10.1016\/j.jpba.2020.113154_bib0080","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.str.2006.05.010","article-title":"Structure of artemin complexed with its receptor GFRalpha3: convergent recognition of glial cell line-derived neurotrophic factors","volume":"14","author":"Wang","year":"2006","journal-title":"Structure."},{"key":"10.1016\/j.jpba.2020.113154_bib0085","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1107\/S1744309109017722","article-title":"Comparison of GFL-GFRalpha complexes: further evidence relating GFL bend angle to RET signaling","volume":"65","author":"Parkash","year":"2009","journal-title":"Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun."},{"key":"10.1016\/j.jpba.2020.113154_bib0090","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22050713","article-title":"Heparin, Heparan Sulphate and the TGF-\u03b2 Cytokine Superfamily","volume":"22","author":"Rider","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2020.113154_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125034","article-title":"First-In-human, double-blind, placebo-controlled, randomized, dose-escalation study of BG00010, a glial cell line-derived neurotrophic factor family member, in subjects with unilateral Sciatica","volume":"10","author":"Rolan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2020.113154_bib0100","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/btpr.2091","article-title":"Integration of cell line and process development to overcome the challenge of a difficult to express protein","volume":"31","author":"Alves","year":"2015","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jpba.2020.113154_bib0105","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/btpr.1873","article-title":"High-throughput ion exchange purification of positively charged recombinant protein in the presence of negatively charged dextran sulfate","volume":"30","author":"Markely","year":"2014","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jpba.2020.113154_bib0110","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1016\/S0021-9258(18)62831-5","article-title":"The gross conformation of protein-sodium dodecyl sulfate complexes","volume":"245","author":"Reynolds","year":"1970","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpba.2020.113154_bib0115","first-page":"341","article-title":"Optimization of conditions for size-exclusion chromatography of proteins","volume":"45","author":"Hagarov\u00e1","year":"1991","journal-title":"Chem. Pap."},{"key":"10.1016\/j.jpba.2020.113154_bib0120","doi-asserted-by":"crossref","first-page":"54S","DOI":"10.1177\/0091270011413894","article-title":"Characterizing the impact of renal impairment on the clinical pharmacology of biologics","volume":"52","author":"Meibohm","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2020.113154_bib0125","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1177\/00912709922011773","article-title":"Disposition of recombinant human interleukin\u201010 in subjects with various degrees of renal function","volume":"39","author":"Andersen","year":"1999","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2020.113154_bib0130","unstructured":"Rossomando A, Silvian L, Pepinsky RB (2012). Neublastin variants, US patent number 8263553."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708519322770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708519322770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:02:16Z","timestamp":1760000536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708519322770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":26,"alternative-id":["S0731708519322770"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113154","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tissue distribution of 35S-metabolically labeled neublastin (BG00010) in rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113154"}}